Search

ResMed Inc

Geschlossen

BrancheGesundheitswesen

226.81 -0.1

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

225

Max

229.33

Schlüsselkennzahlen

By Trading Economics

Einkommen

1.1B

1.5B

Verkäufe

32M

1.5B

KGV

Branchendurchschnitt

21.38

56.432

EPS

2.95

Dividendenrendite

1.1

Gewinnspanne

104.075

Angestellte

11,370

EBITDA

-91M

493M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+5.22% upside

Dividenden

By Acuity

Dividendenrendite

Branchendurchschnitt

1.10%

2.27%

Nächstes Ergebnis

29. Okt. 2026

Nächste Dividendenausschüttung

24. Sept. 2026

Nächstes Ex-Dividendendatum

12. Nov. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

952M

32B

Vorheriger Eröffnungskurs

226.91

Vorheriger Schlusskurs

226.81

Nachrichtenstimmung

By Acuity

43%

57%

110 / 339 Ranking in Healthcare

ResMed Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

16. Sept. 2026, 21:31 UTC

ResMed Inc. is seeing a modest increase in after-hours trading, reaching a peak return of 0.46% following Wednesday's close.

15. Sept. 2026, 22:02 UTC

Social Media

RBC Capital upgraded ResMed Inc to Outperform and raised its price target to $262, with shares trading roughly flat in after-market hours.

9. Sept. 2026, 20:07 UTC

Resmed Inc. shares are lower today amid broader market declines and inflationary pressures tied to rising crude oil prices and interest rate hike speculation.

8. Sept. 2026, 20:02 UTC

News

Resmed Inc shares are lower amid a broader decline in the Health Care Equipment sector, reflecting six consecutive sessions of lower closes.

4. Sept. 2026, 19:47 UTC

Resmed Inc shares are lower, continuing a recent downward trend. No specific news explains today's price movement amid rising Treasury yields and unchanged unemployment figures.

3. Sept. 2026, 22:16 UTC

Resmed Inc. remains roughly flat in after-market trading, with no specific news identified. The stock has faced recent pressure, finishing lower in the last three sessions.

2. Sept. 2026, 20:08 UTC

Resmed Inc. shares are lower today, reflecting broader market declines since Tuesday. The ADP report indicates slower job growth, impacting Federal Reserve rate considerations.

1. Sept. 2026, 23:16 UTC

News

ResMed Inc has initiated a $450 million accelerated share repurchase agreement, contributing to higher shares in after-market trading. Final settlement is set for December 2026.

31. Aug. 2026, 20:07 UTC

ResMed Inc shares are lower today, influenced by Fed officials' comments on inflation and interest rates. Earlier, shares briefly recovered above Friday's close.

28. Aug. 2026, 20:07 UTC

News

Resmed Inc shares are higher today, reaching a session high and exceeding their 20-day moving average amid rising U.S. Treasury yields and inflation concerns.

27. Aug. 2026, 19:36 UTC

Social Media

Resmed Inc's shares are lower amid concerns over its MatrixCare divestiture, which reflects a significant drop in valuation from its 2018 acquisition.

26. Aug. 2026, 20:07 UTC

Resmed Inc shares are lower today, influenced by a decline in the Health Care Equipment sub-sector. No specific company news was identified.

25. Aug. 2026, 23:36 UTC

Shares of Resmed Inc. rose in after-market trading, continuing an upward trend since Tuesday's close despite earlier declines. The stock remains above its 20-day moving average.

24. Aug. 2026, 23:56 UTC

Resmed Inc. shares are lower in after-market hours amid weak trading sentiment. No specific company news was identified to explain the decline.

21. Aug. 2026, 20:06 UTC

ResMed Inc shares are higher today, reflecting broader market trends. The stock remains above its 20-day moving average and near its one-month range.

20. Aug. 2026, 20:06 UTC

Shares of Resmed Inc. are lower amid rising crude oil prices and increasing U.S. Treasury yields, reflecting broader market trends. No specific company news was identified.

19. Aug. 2026, 20:02 UTC

Shares of Resmed Inc. are trading higher today, reflecting strong momentum and significant recovery from earlier session dips.

18. Aug. 2026, 19:41 UTC

News

ResMed Inc. plans a meeting with KeyBanc on August 26 in Montreal. Shares are trading higher since Monday's close, recovering from earlier fluctuations.

17. Aug. 2026, 20:06 UTC

News

ResMed Inc. shares are declining following a Q2 earnings report showing reduced operating margins and a $42 million charge related to safety actions.

14. Aug. 2026, 23:46 UTC

Resmed Inc. shares are lower in after-market hours amid broader market sentiment influenced by a surprising decline in U.S. retail sales for July.

13. Aug. 2026, 19:16 UTC

News

ResMed Inc reports Q2 revenue of $1.46 billion, matching estimates. Shares are higher amid investor sentiment despite challenges from rising costs and a safety charge.

12. Aug. 2026, 21:01 UTC

Resmed Inc. shares are trading lower in after-market hours, continuing a decline that began shortly after Wednesday's close. No specific news was identified.

11. Aug. 2026, 23:26 UTC

Resmed Inc. shares remained roughly flat in after-market hours, reflecting broader market conditions amid investor caution ahead of upcoming inflation data.

10. Aug. 2026, 20:02 UTC

Social Media
News

ResMed reported Q2 2026 sales of $1.46 billion, exceeding expectations. Shares are gaining today, despite earlier pulling back in the session.

8. Aug. 2026, 00:01 UTC

Resmed Inc. shares declined in after-market trading, moving below the 20-day moving average, despite earlier gains since Friday's close.

7. Aug. 2026, 23:41 UTC

News

ResMed shares declined after-market despite RBC Capital raising its price target to $244 and maintaining a Sector Perform rating.

6. Aug. 2026, 23:01 UTC

News

ResMed shares declined in after-market trading despite a fourth-quarter earnings beat. The company reported a non-GAAP EPS of $2.95 and revenue of $1.46 billion.

5. Aug. 2026, 19:11 UTC

News

ResMed Inc shares are higher as the company prepares for earnings on August 5, 2026, following a quarter that exceeded expectations.

4. Aug. 2026, 20:02 UTC

News

ResMed Inc shares are advancing, supported by strong cash flow and global growth. The stock has maintained a notable gain since Monday's close.

3. Aug. 2026, 21:02 UTC

News

ResMed Inc. shares are higher in after-market trading, supported by strong financials and a free cash flow margin of 31.7%.

Peer-Vergleich

Kursveränderung

ResMed Inc Prognose

Kursziel

By TipRanks

5.22% Vorteil

12-Monats-Prognose

Durchschnitt 241.417 USD  5.22%

Hoch 320 USD

Tief 213 USD

Basierend auf 15 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für ResMed Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

15 ratings

5

Buy

10

Halten

0

Sell

Stimmung

By Acuity

110 / 339 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat